Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Fulgent Genetics, Inc. | flgt-ex321_10.htm |
| EX-31.2 - EX-31.2 - Fulgent Genetics, Inc. | flgt-ex312_6.htm |
| EX-31.1 - EX-31.1 - Fulgent Genetics, Inc. | flgt-ex311_9.htm |
| EX-10.38 - EX-10.38 - Fulgent Genetics, Inc. | flgt-ex1038_92.htm |
| EX-10.37 - EX-10.37 - Fulgent Genetics, Inc. | flgt-ex1037_91.htm |
| EX-10.36 - EX-10.36 - Fulgent Genetics, Inc. | flgt-ex1036_89.htm |
| EX-10.35 - EX-10.35 - Fulgent Genetics, Inc. | flgt-ex1035_90.htm |
| EX-10.34 - EX-10.34 - Fulgent Genetics, Inc. | flgt-ex1034_88.htm |
| 10-K - 10-K - Fulgent Genetics, Inc. | flgt-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-239964 on Form S-3 and No. 333-248962 on Form S-8 of our report dated March 8, 2021, relating to the financial statements of Fulgent Genetics, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP
Los Angeles, California
March 8, 2021